142 related articles for article (PubMed ID: 9383733)
1. Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity.
Stephenson GA; Stowell JG; Toma PH; Pfeiffer RR; Byrn SR
J Pharm Sci; 1997 Nov; 86(11):1239-44. PubMed ID: 9383733
[TBL] [Abstract][Full Text] [Related]
2. Phase transformations of erythromycin A dihydrate during pelletisation and drying.
Römer M; Heinämäki J; Miroshnyk I; Sandler N; Rantanen J; Yliruusi J
Eur J Pharm Biopharm; 2007 Aug; 67(1):246-52. PubMed ID: 17270405
[TBL] [Abstract][Full Text] [Related]
3. Phase transformation of erythromycin A dihydrate during fluid bed drying.
Römer M; Heinämäki J; Miroshnyk I; Kivikero N; Sandler N; Rantanen J; Yliruusi J
J Pharm Sci; 2008 Sep; 97(9):4020-9. PubMed ID: 18200525
[TBL] [Abstract][Full Text] [Related]
4. Influence of solvents on the variety of crystalline forms of erythromycin.
Mirza S; Miroshnyk I; Heinämäki J; Christiansen L; Karjalainen M; Yliruusi J
AAPS PharmSci; 2003; 5(2):E12. PubMed ID: 12866939
[TBL] [Abstract][Full Text] [Related]
5. Physico-chemical characterization of interactions between erythromycin and various film polymers.
Sarisuta N; Kumpugdee M; Müller BW; Puttipipatkhachorn S
Int J Pharm; 1999 Sep; 186(2):109-18. PubMed ID: 10486428
[TBL] [Abstract][Full Text] [Related]
6. Ring-chain tautomerism in solid-phase erythromycin A: evidence by solid-state NMR.
Iuliucci RJ; Clawson J; Hu JZ; Solum MS; Barich D; Grant DM; Taylor CM
Solid State Nucl Magn Reson; 2003 Aug; 24(1):23-38. PubMed ID: 12850255
[TBL] [Abstract][Full Text] [Related]
7. Solid state dehydration processes: mechanism of water loss from crystalline inosine dihydrate.
Gillon AL; Davey RJ; Storey R; Feeder N; Nichols G; Dent G; Apperley DC
J Phys Chem B; 2005 Mar; 109(11):5341-7. PubMed ID: 16863200
[TBL] [Abstract][Full Text] [Related]
8. Reversible crystal transition of guanosine between the dihydrate and anhydrous states coupled with adsorption-desorption process.
Sugawara Y; Iimura Y; Iwasaki H; Urabe H; Saito H
J Biomol Struct Dyn; 1994 Feb; 11(4):721-9. PubMed ID: 8204210
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic characterization of several erythromycin A solvates: the environment of the solvent molecules in the crystal lattice.
Henry R; Zhang GG
J Pharm Sci; 2007 May; 96(5):1251-7. PubMed ID: 17455320
[TBL] [Abstract][Full Text] [Related]
10. Understanding processing-induced phase transformations in erythromycin-PEG 6000 solid dispersions.
Mirza S; Heinämäki J; Miroshnyk I; Rantanen J; Christiansen L; Karjalainen M; Yliruusi J
J Pharm Sci; 2006 Aug; 95(8):1723-32. PubMed ID: 16795009
[TBL] [Abstract][Full Text] [Related]
11. Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation.
Bauer JF; Dziki W; Quick JE
J Pharm Sci; 1999 Nov; 88(11):1222-7. PubMed ID: 10564073
[TBL] [Abstract][Full Text] [Related]
12. Crystal forms of LY334370 HCl: isolation, solid-state characterization, and physicochemical properties.
Reutzel-Edens SM; Kleemann RL; Lewellen PL; Borghese AL; Antoine LJ
J Pharm Sci; 2003 Jun; 92(6):1196-205. PubMed ID: 12761809
[TBL] [Abstract][Full Text] [Related]
13. Study and characterization of crystalline hydrate/polymorph forms of 5,11-dihydro-11-ethyl-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepin-6-one by solid-state NMR and solution NMR.
Gonnella NC; Smoliga JA; Campbell S; Busacca CA; Cerreta M; Varsolona R; Norwood DL
J Pharm Biomed Anal; 2010 Apr; 51(5):1047-53. PubMed ID: 20018474
[TBL] [Abstract][Full Text] [Related]
14. Formation of isomorphic desolvates: creating a molecular vacuum.
Stephenson GA; Groleau EG; Kleemann RL; Xu W; Rigsbee DR
J Pharm Sci; 1998 May; 87(5):536-42. PubMed ID: 9572901
[TBL] [Abstract][Full Text] [Related]
15. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
[TBL] [Abstract][Full Text] [Related]
16. Structure determination from conventional powder diffraction data: application to hydrates, hydrochloride salts, and metastable polymorphs.
Stephenson GA
J Pharm Sci; 2000 Jul; 89(7):958-66. PubMed ID: 10861598
[TBL] [Abstract][Full Text] [Related]
17. Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy.
Mordi MN; Pelta MD; Boote V; Morris GA; Barber J
J Med Chem; 2000 Feb; 43(3):467-74. PubMed ID: 10669574
[TBL] [Abstract][Full Text] [Related]
18. Preparation and solid state characterisation of chlorothiazide sodium intermolecular self-assembly suprastructure.
Paluch KJ; Tajber L; McCabe T; O'Brien JE; Corrigan OI; Healy AM
Eur J Pharm Sci; 2010 Dec; 41(5):603-11. PubMed ID: 20816757
[TBL] [Abstract][Full Text] [Related]
19. Structural studies of a non-stoichiometric channel hydrate using high resolution X-ray powder diffraction, solid-state nuclear magnetic resonance, and moisture sorption methods.
Kiang YH; Cheung E; Stephens PW; Nagapudi K
J Pharm Sci; 2014 Sep; 103(9):2809-2818. PubMed ID: 24470123
[TBL] [Abstract][Full Text] [Related]
20. Understanding the dehydration of levofloxacin hemihydrate.
Gorman EM; Samas B; Munson EJ
J Pharm Sci; 2012 Sep; 101(9):3319-30. PubMed ID: 22610517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
